Single-Nucleus RNA Sequencing and Spatial Transcriptomics for Squamous Cell Carcinoma Arising From Ovarian Mature Teratoma
- Kosuke Yoshida 1,2,3, Akira Yokoi 1,2, Hironori Suzuki 1,3, Satoshi Tamauchi 1, Masami Kitagawa 1, Eri Inami 1, Jun Nakayama 3,4, Yutaro Mori 5, Koji Okamoto 5, Yutaka Suzuki 6, Hiroshi Yoshida 7, Tomoyasu Kato 8, Hiroaki Kajiyama 1, Yusuke Yamamoto 3
- Kosuke Yoshida 1,2,3, Akira Yokoi 1,2, Hironori Suzuki 1,3
- 1Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
- 2Institute for Advanced Research, Nagoya University, Nagoya, Japan.
- 3Laboratory of Integrative Oncology, National Cancer Center Research Institute, Tokyo, Japan.
- 4Department of Oncogenesis and Growth Regulation, Research Institute, Osaka International Cancer Institute, Osaka, Japan.
- 5Advanced Comprehensive Research Organization, Teikyo University, Tokyo, Japan.
- 6Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Japan.
- 7Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan.
- 8Department of Gynecology, National Cancer Center Hospital, Tokyo, Japan.
- 0Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Squamous cell carcinoma arising from mature teratoma (SCC-MT) is a rare ovarian cancer. This study reveals KLF5 as a key driver in SCC-MT development, suggesting KLF5-related factors as potential therapeutic targets.
Area Of Science
- Gynecologic Oncology
- Molecular Pathology
- Cancer Genomics
Background
- Squamous cell carcinoma arising from mature teratoma (SCC-MT) is a rare ovarian malignancy with poorly understood molecular pathology and limited treatment options.
- The poor prognosis of SCC-MT patients underscores the urgent need for novel therapeutic strategies.
Purpose Of The Study
- To elucidate the molecular pathology of SCC-MT using advanced multi-omics approaches.
- To identify novel therapeutic targets for SCC-MT.
Main Methods
- Single-nucleus RNA sequencing (snRNA-seq) and spatial transcriptomics on clinical SCC-MT samples.
- Functional analysis of KLF5 using the NOSCC-1 cell line.
- Investigation of miR-145-5p's role in SCC-MT.
Main Results
- snRNA-seq identified epithelial cell clusters associated with keratinocyte development.
- Spatial transcriptomics indicated inhibited epithelial-mesenchymal transition and activated MYC/E2F targets in cancer cells.
- KLF5 downregulation reduced SCC-MT cell proliferation and increased apoptosis; miR-145-5p overexpression decreased KLF5 expression.
Conclusions
- Multi-omics analyses revealed unique gene expression profiles in SCC-MT.
- KLF5 plays a significant role in SCC-MT development and progression.
- KLF5-related factors represent promising novel therapeutic targets for SCC-MT, warranting further investigation.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

